A relationship between sympathetic nerve dysfunction and cardiovascular morbidity and
mortality has been recognized for decades yet there has only recently been interest in
applying sympathetic nerve imaging to the clinical management of patients with heart
disease. With the increasing availability of nuclear tracers of norepinephrine it is likely that in
the near future non-invasive imaging of sympathetic function will be translated from the
realm of research to the clinical armamentarium. This brief review will focus on sympathetic�…